C. Marchant

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

M. Keller, Roger A. Freedman, James Coromilas, 1997, The New England journal of medicine.

Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial.

S. Chugh, J. Cook, J. Mcanulty, 2005, JAMA.

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

W. J. Hamilton, Randall C. Thompson, David C. Anderson, 1996, The Lancet.

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.

Robert Lemery, M Huther, D Brill, 1992, The New England journal of medicine.

Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Economic Analysis Substudy

G. Larsen, M. Brodsky, A. Hallstrom, 2002, Circulation.

Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators.

Diane M. Miller, David C. Anderson, V. Fuster, 1990, Stroke.